Spencer has been involved in the development of instrumentation and software for the Life Sciences for over 2 decades. Prior to Halo Labs, Spencer was Sr. Director of R&D for ForteBio (the biologics business unit of Molecular Devices) and responsible for leading a team of engineers and scientists through the technical and strategic challenges of developing the next generation of assays, consumables and instruments for protein characterization and Biologics discovery. Before ForteBio, Spencer held senior positions at Molecular Devices, MDS Analytical Technologies, and Axon Instruments, where he was involved with the development of market-leading analytical tools for imaging and bioinformatics. Spencer holds a B.S. in Cellular, Molecular and Microbial Biology from the University of Calgary.
Bernardo leads application and business development, and is one of the Halo Labs’ founders. He has was previously CEO and CTO, and played a pivotal role in bringing over $6M in federal grant funding. Prior to starting Halo Labs, Bernardo was a Postdoctoral Associate at Cornell University, where he also obtained his M.S. and Ph.D. degrees in Mechanical Engineering. His wide range of technical experience includes particle analysis, detection and manipulation, drug delivery devices, microfluidics, nanophotonics and bioenergy production. In 2012, Bernardo was named one of Philadelphia’s top 30 under 30 entrepreneurs, the same year Halo Labs was named Philadelphia Life Science Startup of the year by the Greater Philadelphia Alliance for Capital and Technologies.
Rick comes to Halo Labs with over 15 years of sales and sales management experience in start-up, emerging growth, and market-leading life science tools companies. Prior to joining Halo Labs, Rick held senior positions at Unchained Labs and Phasefocus, where he launched and built sales organizations and was a key member of the team that grew ForteBio into the bestselling label-free protein characterization platform on the market. Rick has also held sales positions at Molecular Devices, LabKey Software, and Pacific Biomarkers. Rick holds a B.S. in Biology from the University of Washington and an M.S. in Biology from the University of Maine.
Robert has over 25 years of experience in life science instrumentation and product development. Before Halo, Robert was General Manager of Pall ForteBio responsible for growing the company with YOY growth of over 25% every year for four years. Robert was also the Senior VP of Instrumentation R&D at Pall Corporation and a corporate M&A member, helping acquire a variety of companies into Pall’s numerous markets. Before Pall, Robert was VP of Product Development and Operations for ForteBio from 2007 to 2012 where he helped exit the company to Pall Corporation for over $160M. Before that, Robert was at Molecular Devices Corporation, where he was Vice President of Product Development, being on the executive team that helped the $615M acquisition by MDS. Previously he was at Axon Instruments, Inc. for 13 years, as Vice President of Software Engineering, helping be the first private company to IPO on the Australian stock market, and then helped with the $140 million acquisition by Molecular Devices. Robert received a BA in Computer and Information Sciences and Mathematics from Drew University, NJ and an MS in Computer and Information Sciences from the University of Oregon.
Cristina comes to Halo Labs with over 15 years of finance and accounting experience. Prior to joining Halo Labs as Controller in 2018, Cristina worked at Unchained Labs and Pall Fortebio where she helped establish key processes and controls in finance. She also worked for Avigen, a publicly traded gene-therapy and small molecules company, where she oversaw the financial reporting obligations and was responsible for Sarbanes-Oxley compliance. Cristina holds a B.S. in Economics from the University of the Philippines.
Bettina joined Halo Labs with a shared expertise in quality management and QC development as well as a broad hands-on research and product development background in both academic and corporate environments. She graduated as Biological Technical Assistant in Germany and started her career path as a researcher at the prestigious Max-Planck-Institute for Biochemistry in Martinsried before joining the Suzanne Pfeffer Lab at Stanford University followed by Zyomyx, a proteomics start-up company.
Among her accomplishment during her 15-year tenure at ForteBio, she developed essential assays and surface chemistries for the early Octet platform before spear-heading the development of a range of consumable products. She later led all Quality Operations at Fortebio and was responsible for building and managing the Quality Control / Quality Engineer team. She was also the leading contributor for ForteBio’s ISO 9001 certification under Molecular Devices.